David Dadiomov

David Dadiomov, PharmD, BCPP, serves as an Assistant Professor of Clinical Pharmacy in the Titus Family Department of Clinical Pharmacy at the University of Southern California School of Pharmacy. He also directs the PGY2 Psychiatric Pharmacy Residency Program and maintains an active clinical practice at Los Angeles General Medical Center.

Education

• PharmD from University of Michigan College of Pharmacy
• PGY1 Pharmacy Residency at University of Michigan Health
• PGY2 Psychiatric Pharmacy Residency at University of California-San Diego Health

Dadiomov's research focuses on substance use disorders, addiction medicine, and psychiatric pharmacy with particular expertise in opioid use disorder treatment, harm reduction strategies, and psychopharmacology. His work addresses critical healthcare gaps for vulnerable populations including individuals experiencing homelessness, those recently released from incarceration, and patients with severe mental illness. He has established innovative clinical pharmacy services through collaborations with the LA County Department of Health Services.

Analysis of Dadiomov's publications reveals a strong focus on medication access barriers, particularly regarding buprenorphine and naloxone distribution during the pandemic. His research spans multiple settings including community pharmacies, correctional facilities, and telemedicine platforms. The publications demonstrate expertise in both clinical psychopharmacology (particularly ketamine/esketamine treatments) and public health approaches to substance use disorders.

Professional Recognition

• Board Certified Psychiatric Pharmacist (BCPP)

Dadiomov actively mentors pharmacy residents through the PGY2 Psychiatric Pharmacy Residency Program he directs. His research has been supported by the Foundation for Opioid Response Efforts for a project focused on overcoming pharmacy-level barriers to Medications for Opioid Use Disorder (MOUD) dispensing. This work aims to create evidence-based practice guidelines and educational programming to encourage pharmacists to dispense buprenorphine.

His clinical work bridges academic medicine and community healthcare, with particular emphasis on creating low-barrier access to addiction treatment services. Dadiomov has been featured in major media outlets including the LA Times, NBC, and USC News discussing topics ranging from psychedelic therapies to street-level addiction treatment approaches in Skid Row.